Economic Observation Network Tongrentang Guoyao (03613) has recently obtained the approval of the relevant regulatory authorities in Hong Kong and Macao for the registration and listing of two traditional Chinese patent medicines and simple preparations, which currently has no significant impact on the company's performance.

Recent Events
On October 9, it was announced that it had obtained the registration certificate of traditional Chinese patent medicines and simple preparations in Hong Kong, allowing "Dingzhi Pill [Tongrentang]" to be sold in Hong Kong, with registration number HKC-18863, valid until September 29, 2031 The medicine is mainly used for tonifying qi, nourishing the heart, calming the mind, and calming the mind. The research and development investment is about HKD 800000, and it has not yet been launched for sale. The company has clearly stated that it will not have a significant impact on performance at this time 。

On October 14, it was announced that the subsidiary Tongrentang (Macao) Co., Ltd. was approved by the Macao Food and Drug Administration to sell six traditional Chinese patent medicines and simple preparations in Macao, including "Shiliantong Granules", "Shugan Jianwei Pills" 。

The above content is based on publicly available information and does not constitute investment advice.